Back
Journey Medical 10K Form
Sell
41
DERM
Journey Medical
Last Price:
5.15
Seasonality Move:
24.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-14 | 10Q | DERM/Journey Medical Quarterly |
| 2023-11-13 | 10Q | DERM/Journey Medical Quarterly |
| 2023-08-10 | 10Q | DERM/Journey Medical Quarterly |
| 2023-05-22 | 10Q | DERM/Journey Medical Quarterly |
| 2022-11-10 | 10Q | DERM/Journey Medical Quarterly |
| 2022-08-09 | 10Q | DERM/Journey Medical Quarterly |
Receive DERM News And Ratings
See the #1 stock for the next 7 days that we like better than DERM
DERM Financial Statistics
Sales & Book Value
| Annual Sales: | $79.18M |
|---|---|
| Cash Flow: | $-5.18M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.56 |
| Price / Book: | 9.49 |
Profitability
| EPS (TTM): | -0.02000 |
|---|---|
| Net Income (TTM): | $843K |
| Gross Margin: | $52.52M |
| Return on Equity: | 6.8% |
| Return on Assets: | 1.22% |
Journey Medical Earnings Forecast
Key Journey Medical Financial Ratios
- The Gross Profit Margin over the past 5 years for DERM is 66.33%.
- The Selling, General & Administrative Expenses for DERM have been equal to 55.46% of Gross Profit Margin.
- The Research & Development expenses have been 9.52% of Revenue.
- The Interest Expense is -44.07% of Operating Income.
- The Net Earning history of DERM is -4.87% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 3 years.
Journey Medical Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | DERM |
| CUSIP: | 24983L |
| Website: | journeymedicalcorp.com |
Debt
| Debt-to-Equity Ratio: | 1.75 |
|---|---|
| Current Ratio: | 1.36 |
| Quick Ratio: | 1.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DERM Technical Analysis vs Fundamental Analysis
Sell
41
Journey Medical (DERM)
is a Sell
Is Journey Medical a Buy or a Sell?
-
Journey Medical stock is rated a Sell
The current Journey Medical [DERM] share price is $5.17. The Score for DERM is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.